Mr Shmuel Vasser > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Mr Shmuel Vasser
Work Department
Financial Restructuring
Position
Partner
Career
Shmuel Vasser has broad experience in some of the largest and most complex restructurings and reorganizations. Mr. Vasser’s notable engagements include the representation of the consortium of lenders in the threatened collapse of Long Term Capital and the Chicago Mercantile Exchange as the designated self-regulatory organization for Refco, LLC.
Mr. Vasser has represented debtors, creditors, lenders, hedge funds, private equity funds and acquirers of distressed assets and securities. He has experience in restructurings, prepackaged cases, debtor in possession financings, assets sales, and litigation and acquisition transactions involving troubled companies. Mr. Vasser’s practice includes bankruptcy issues concerning structured finance transactions; derivative instruments, including swaps, forward contracts, and repurchase agreements; and other sophisticated financial products.
Memberships
- ABI Commission to Study the Reform of Chapter 11, Financial Contracts, Derivatives and Safe Harbors Advisory Committee
Education
- New York University School of Law, LL.M.
- Tel Aviv University, LL.B.
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation